CTS trades 24.7% below Wall Street's consensus target of $73.50.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CTS achieves its forward estimates and maintains a stable P/E multiple of 22.2x. This scenario reflects the blended consensus of 4 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of September 23, 2026, CTS Corporation (CTS) has a Wall Street consensus price target of $73.50, based on estimates from 4 covering analysts. With the stock currently trading at $58.95, this represents a potential upside of +24.7%. The company has a market capitalization of $1.68B.
Analyst price targets range from a low of $67.00 to a high of $80.00, representing a 18% spread in expectations. The median target of $73.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 1 analysts rating the stock as a Buy or Strong Buy,3 rating it Hold, and 0 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, CTS trades at a trailing P/E of 26.9x and forward P/E of 22.2x. The forward PEG ratio of 1.42 indicates reasonable valuation for growth. Analysts expect EPS to grow +10.1% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $78.80, with bear and bull scenarios of $49.64 and $103.82 respectively. Model confidence stands at 48/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 KLICKulicke and Soffa Industries, Inc. | $4.7B | $89.54 | $62.50 | -30.2% | Buy | 23.2x | 11 |
 VICRVicor Corporation | $12.2B | $268.34 | $347.50 | +29.5% | Buy | 78.1x | 7 |
 INTTinTEST Corporation | $142M | $11.32 | $15.00 | +32.5% | Buy | 25.7x | 5 |
 PLXSPlexus Corp. | $7.0B | $263.33 | $305.00 | +15.8% | Buy | 30.3x | 18 |
 AVXAvax One Technology Ltd | $36M | $4.50 | — | — | — | — | — |
 MLABMesa Laboratories, Inc. | $753M | $134.63 | $110.00 | -18.3% | Hold | 14.9x | 8 |
 NOVTNovanta Inc. | $5.1B | $144.17 | $194.00 | +34.6% | Buy | 39.0x | 3 |
 OSISOSI Systems, Inc. | $3.3B | $200.84 | $287.00 | +42.9% | Buy | 19.3x | 18 |
 GRMNGarmin Ltd. | $54.9B | $284.67 | $320.25 | +12.5% | Hold | 28.0x | 28 |
 MCHPMicrochip Technology Incorporated | $41.2B | $75.82 | $110.50 | +45.7% | Buy | 48.4x | 46 |
Quick answers to the most common questions about buying CTS stock.
The consensus Wall Street price target for CTS is $73.5, representing 24.7% upside from the current price of $58.95. With 4 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
CTS has a consensus rating of "Hold" based on 4 Wall Street analysts. The rating breakdown is mixed, with 3 Hold ratings making up the largest segment. The consensus 12-month price target of $73.5 implies 24.7% upside from current levels.
CTS trades at a forward P/E of 22.2176x, representing a moderate valuation. With analysts targeting $73.5 (24.7% implied move), the stock appears reasonably valued with upside.
The most bullish Wall Street analyst has a price target of $80 for CTS, while the most conservative target is $67. The consensus of $73.5 represents the median expectation. Our quantitative valuation model projects a bull case target of $104 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CTS is lightly followed, with 4 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 3 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CTS stock forecast based on 4 Wall Street analysts shows a consensus price target of $73.5, with estimates ranging from $67 (bear case) to $80 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $79, with bear/bull scenarios of $50/$104.
Our quantitative valuation model calculates CTS's fair value at $79 (base case), with a bear case of $50 and bull case of $104. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 48/100.
CTS trades at a forward P/E ratio of 22.2x based on next-twelve-months earnings estimates compared to a trailing P/E of 26.9x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on CTS, with a "Hold" consensus rating and $73.5 price target (24.7% upside). 1 of 4 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CTS analyst price targets range from $67 to $80, a 18% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $73.5 consensus represents the middle ground. Our model's $50-$104 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.